Systematic review with meta ‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patients

ConclusionsPatients undergoing liver transplant are more prone to experience diabetes, hypertension or dyslipidaemia, and NAFLD may be an important element in this context. In this study, we show how the prevalence of NASH tends to remain significant and similar to the general population. Moreover, this study suggests a possible association with specific transplant indications. Further studies are required to confirm these findings.

Source: Alimentary Pharmacology and Therapeutics - January 23, 2018 Category: Drugs & Pharmacology Authors: G. Losurdo, A. Castellaneta, M. Rendina, S. Carparelli, G. Leandro, A. Di Leo Tags: SYSTEMATIC REVIEW WITH META ‐ANALYSIS Source Type: research